First-in-human study of HyperQure for resistant hypertension
Part of Heart & circulation clinical trials.
This study tests a new surgical procedure called HyperQure laparoscopic renal denervation for people with resistant hypertension (high blood pressure that does not respond well to multiple medications). The goal is to see if it can safely lower blood pressure. The procedure uses a small incision in the back to reach the kidney nerves and quiet them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 79 years old
- You have resistant hypertension and take at least 3 blood pressure medications, including a diuretic, and have been on the same doses for at least 4 weeks
- Your blood pressure in the office is 140/90 or higher, and daytime average systolic blood pressure is 135 or higher
- You do not have severe kidney problems, kidney artery narrowing, or other conditions that would make the procedure unsafe
- You are willing to continue your current blood pressure medications for at least 3 months after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment called HyperQure RDN, a laparoscopic (keyhole) surgery that targets nerves near the kidneys to lower blood pressure in people with resistant hypertension. If you have tried multiple medications but your blood pressure is still high, this procedure might offer an alternative approach.
This study looks at a procedure called renal denervation, which uses a device to calm overactive nerves in the kidneys that can drive high blood pressure. It is for people whose blood pressure stays high even with several medications, or who cannot tolerate blood pressure pills.
This trial tests a procedure called renal denervation (using radiofrequency energy to calm overactive kidney nerves) in people who have chest pain caused by tiny heart artery dysfunction and also have hard-to-control high blood pressure. The goal is to see if treating the kidney nerves improves blood flow in the small heart arteries.
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
This trial tests a procedure that targets nerves near the kidney (renal denervation) to help lower blood pressure in people whose hypertension is not controlled despite medication. It uses a special 3D mapping system to guide the procedure.
This trial tests a new device procedure (renal denervation) to lower blood pressure in people whose high blood pressure is not well controlled by medications or who cannot tolerate them. If you have resistant hypertension and meet the safety criteria, you may be able to join.
Hear when a new Resistant Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.